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Background: Many studies on M. tuberculosis have emerged from using M. smegmatis MC2155 (Msm), since they share
significant similarities and yet Msm is non-pathogenic and faster growing. Although several individual molecules have
been studied from Msm, many questions remain open about its metabolism as a whole and its capability to be
versatile. Adaptability and versatility are emergent properties of a system, warranting a molecular systems perspective
to understand them.
Results: We identify feasible metabolic pathways in Msm in reference condition with transcriptome, phenotypic
microarray, along with functional annotation of the genome. Together with transcriptome data, specific genes from a
set of alternatives have been mapped onto different pathways. About 257 metabolic pathways can be considered to
be feasible in Msm. Next, we probe cellular metabolism with an array of alternative carbon and nitrogen sources and
identify those that are utilized and favour growth as well as those that do not support growth. In all, about 135 points
in the entire metabolic map are probed. Analyzing growth patterns under these conditions, lead us to hypothesize
different pathways that can become active in various conditions and possible alternate routes that may be induced,
thus explaining the observed physiological adaptations.
Conclusions: The study provides the first detailed analysis of feasible pathways towards adaptability. We obtain
mechanistic insights that explain observed phenotypic behaviour by studying gene-expression profiles and pathways
inferred from the genome sequence. Comparison of transcriptome and phenome analysis of Msm and Mtb provides
a rationale for understanding commonalities in metabolic adaptability.
Keywords: Mycobacterium smegmatis, Feasible metabolic paths, Phenotypic microarray, Gene expression,
Gene redundancy, AdaptationBackground
Mycobacterium smegmatis MC2 155 has been extensively
used as a model organism to study various processes in
Mycobacterium tuberculosis (Mtb). It closely resembles
Mtb, and at the same time is non-pathogenic and has
the added advantage of a much shorter doubling time
than Mtb, making it both safe and practical to culture in
the laboratory [1,2]. Resemblances between the two are seen
at various levels. The two species show similar reactions to
acid-fast staining, have similar cell wall structures, both
synthesize mycothiol, exhibit adaptation in microaerobic* Correspondence: nchandra@biochem.iisc.ernet.in
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unless otherwise stated.conditions in absence of carbon, nitrogen and phosphorous
and are capable of biofilm formation [3,4]. High levels
of similarities are also seen in the individual genes
between the two species [5,6]. Studies have been carried
out in Msm to screen for probable drug candidates
for tuberculosis [7-9].
Despite the use of Msm for several decades now, very
little is understood about it from a molecular systems
perspective, principally because majority of studies have
focused on individual molecules. Although, the genome
of Msm has been sequenced, there are no published articles
reporting comprehensive analysis and annotation [10]. It is
also known that the genome has high extent of redundancy.
From conventional microbiology studies, it has been
well known that the bacteria can grow under a varietyLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
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and nitrogen sources [11,12]. Msm is also known to occur
in many environmental niches [11]. There is however, no
clear understanding about how the bacterium is able to
exhibit such versatility. Adaptability is essentially systems
property and cannot be explicitly explained by studying
molecules individually [13]. Hence a systems approach is
necessary to understand it [14].
Whole genome sequences of hundreds of bacterial
species are available, providing an excellent starting point
for systems level analysis [15]. The ease of transcriptomics
has led to higher-level data for many species in terms of
genome-wide gene expression values, facilitating more real-
istic reconstruction of systems. However, to understand
physical behavior of the organism, phenotypic data
becomes essential [16]. Phenotypic microarray experiments,
where growth patterns of a given system are studied under
hundreds of conditions, provide a platform to record the
phenotypic behaviour of the organism in a high-throughput
manner. Indeed phenotypic microarray data has now been
reported for several species [17,18]. At present, data from
each of these studies are analysed independently and
inferences made based on that. In principle, data from
multiple perspectives of the same system although
may seem disparate at the outset, should in principle be
consistent and be able to provide cross-explanations for
various observations. However, connecting diverse pieces
of data is a daunting task, due to difficulty in obtaining
genome-to-phenome mapping. The scale in terms of
number of components required to be considered for
genome-wide studies increases the complexity further.
There are very few studies so far in literatures that report
such an integrated view of an organism [19,20]. In
this study, we obtain phenotypic data for Msm in 284
conditions, obtain transcriptome profiles for the reference
condition and analyse the genome sequence for functional
annotation and to identify alternate enzymes. We then
integrate them together to identify feasible metabolic
pathways in Msm in the reference condition and rationalize
phenotypic behavior of Msm under different conditions.
Results
Description of the Msm genome
Mycobacterium smegmatis, a non-pathogenic, saprophytic,
acid-fast, rod-shaped bacterium, has a GC rich genome of 7
Mbp, consisting of about 6938 genes. MC2 155, a reference
strain of M. smegmatis is studied here, since it is
widely used for experimental procedures because of
its transformable morphotype [10,21-23]. Although genome
sequence of M. smegmatis MC2 155 (Msm) has been
available, its genome annotation remains highly incomplete
[10]. However, much can be gained by carrying out se-
quence analysis of Msm proteins and inferring function
from well-annotated homologues in sequence databases,such as Mtb. Msm genome codes for 6716 distinct proteins
of which 1064 are cellular enzymes. Homologues with
either high confidence or previously assigned function in
the sequence databases were identified for 6371 proteins,
enabling transfer of Tuberculist functional categories [24]
to the Msm proteins. No homologues were identified for
about 345 genes and hence their function remained
unassigned. Figure 1a illustrates distribution of functional
categories assigned for the Msm genome. A detailed gene
locus list and the assigned functional categories for Msm
proteins are listed in the Additional file 1. The Venn
diagram in Figure 1b depicts common and unique genes
between Msm and Mtb, which indicate that majority of the
Mtb proteins have homologues in Msm, leaving out only
343 proteins to be unique to Mtb. A large number of
proteins, which sum up to nearly 2400, majorly being
classified into conserved hypotheticals, are seen to be
present in Msm but not in Mtb. Other features that
stand out when Msm is compared to Mtb are (a) about 10
PE and PPE genes present in Msm, as compared to about
168 proteins in Mtb, (b) a larger proportion of genes, sum-
ming up to about 1800, belong to conserved hypotheticals
and (c) a significant reduction of genes in the virulence
category. About 1064 enzymes are identified in Msm as
compared to about 1258 in Mtb. It can be seen in Figure 1c
that the distribution across EC classes are similar in Mtb
and Msm. There appears to be a marginally higher number
of isomerases (158) and lyases (62) in Msm as compared to
119 and 45 in Mtb. The significance of this, if any, is not
readily comprehendible. However, it has been suggested by
Titgemeyer et al., that Msm is a saprophyte unlike Mtb
and may have evolved more isomerases to be able to utilize
a wide range of carbon sources [11]. In any case, the height
of the Msm genome is larger with an additional 2000 genes
and an increase in the some categories can be easily
expected. We in fact observe several instances of gene
duplications. Given the difference in the genome sizes
between Msm and Mtb, we systematically studied the
extent of redundancy in the genome. Figure 1d indicates
the extent of duplication in the genome, which includes
about 170 proteins functionally identified as insertion
sequences and transposases.
Use of gene expression profiles to identify feasible
metabolic pathways in Msm
The Msm transcriptome
A gene-expression profile collected for the whole genome
for cells grown in reference condition indicates that nearly
the entire genome was probed in the array. The reference
medium is composed of Middlebrook 7H9 broth, supple-
mented with glucose, glycerol and Tween 80 and reflects a
standard wild type condition. We term this as the ‘reference
condition’ hereafter. The expression patterns for the 2 bio-
logical replicates were seen to be highly similar (Figure 2)
Figure 1 Functional categories of M.smegmatis MC2 155 genome and gene redundancy. (a) The pie chart depicts distribution of the
functional categories of Msm protein coding genes. (b) Venn diagrams depicting common and unique proteins present in M. smegmatis MC2
155 and M. tuberculosis H37Rv based on sequence homology studies (the number mentioned in parentheses are the Mtb proteins common with
Msm) (venn diagrams: top with 30% sequence similarity as threshold, bottom with 50% sequence similarity as threshold) (c) The distribution of
Msm and Mtb enzymes classified according to their EC classes (d) Self similarity dot plot of the Msm genome depicting gene redundancy. X and
y-axis represent gene indices.
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Hence, average gene expression was calculated for the
samples and the value has been used for other ana-
lyses [25]. Frequency distributions of normalized gene
expression in the replicate arrays showing similar pattern
in both, reflects a normal distribution. About 5018,
3278, 1597 and 676 genes out of 6761 genes probed
using the microarray chip showed values higher than
25th, 50th, 75th and 90th percentile expression respectively
(Additional file 2).Identifying feasible metabolic pathways
In order to identify metabolic pathways active in Msm in
log phase cultures in the reference condition, we map
inferred enzyme abundances from gene expression values
of individual genes, for all pathways in the organism listed
in standard databases, KEGG and BioCyc [26,27]. For a
pathway to be active, enzymes in it must be expressed in
detectable quantities. Although gene-expression does not
always directly correlate with protein abundances, tran-
scription data is clearly suggestive of whether or not a
Figure 2 Microarray data analysis and correlation between the biological replicates. (a) Gene expression profile for all genes in Msm.
(b) Enlarged portion of the heat map. The expression values are colour coded based upon the extent of expression where red indicates high
levels of expression (c) Correlation plot for the biological replicates (R=0.99) and histograms depicting the distribution of the gene expression in
the respective samples.
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correlation between expression levels and protein abun-
dances has been reported for bacterial systems [25,28]. 338
pathways are identified for Msm that combines knowledgeof experimentally known pathways from literature along
with those inferred from genome sequence analysis.
Genes corresponding to enzymes in expected path-
ways including central carbon metabolism, amino acid
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metabolism, mycolic acid biosynthesis are all expressed, as
expected. Figure 3a and b shows gene expression pattern
corresponding to enzymes in some pathways (data for all
338 pathways is given in Additional file 2), which illustrates
that many pathways including those of central carbon
metabolism, as expected, appear active owing to expression
of all required genes. However expression levels vary from
low to high, which is quite understandable owing to their
individual biochemical properties. In all, 257 pathways
can be considered to be active in the condition studied
(for example, the first and second row in Figure 3b). There
are about 14 pathways in which the genes show no expres-
sion (for example, last row in Figure 3b), and about 57
pathways where few genes in them are expressed whereas
75 pathways had most of the genes expressed. The latter
have implications of ease of adaptability (discussed in a
later section).
Another interesting feature that emerges from this
analysis is the identification of the active enzyme(s) fromFigure 3 Representation of the feasible pathways identified from tran
pathways with enzymes vertically ordered from bottom to top. They are co
expression. Multiple boxes present in a single layer depict the alternate gen
level of gene expression in reference condition (c) Schematic illustrating al
orange (d) Multiple sequence alignment of tpi (triose phosphate isomerase
along with catalytic site residues (*) are shown.the set of duplicates available for a given reaction. We
analysed the expression patterns of 24 such sets of dupli-
cate genes in terms of their contribution to their respective
pathways. The trend that we observe indicates that in most
cases only one of the possible alternatives is expressed
(above median levels), while others are not, reflecting that
there is minimisation of cellular expenditure in expressing
redundant enzymes. In very few cases, more than one
gene at a given step are simultaneously expressed.
Figure 3c summarises our observations. Enzymes such as
glucose-6-phosphate isomerase, 6-phosphofructokinase,
fructose-bisphosphate aldolase, phosphoglycerate mutase,
pyruvate kinase are encoded by more than 1 gene.
MSMEG_3086, MSMEG_6785 code for triose phosphate
isomerase enzyme. A multiple sequence alignment shown
in Figure 3d indeed indicates that they are similar to each
other [29]. It is interesting to observe that, of these
two enzymes, only MSMEG_3086 is expressed. They
are located 3674434 bp away from each other at positions
in the chromosome. Similarly, other sets of paralogues arescriptomics and phenotypic analysis. (a) Selected metabolic
lored in grey scale based on the extent of normalized gene
es encoding similar enzymes. (b) Representative pathways with the
ternate enzymes being highly expressed in glycolysis, highlighted in
) for Mtb and two Msm proteins. Sequence identity and conservation
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indicating different transcriptional regulation. This analysis
helps in associating specific genes to individual pathways,
which becomes necessary for systems level modeling of
metabolism, understanding of genomic deletions and any
such genotype to phenotype associations. More examples
of enzymes present in central carbon metabolism are
shown in Additional file 3.
Growth profiles of Msm observed using phenotypic
microarray
In order to characterize the growth profile of the organism
under different nutrient conditions, phenotypic microarray
(PM) analysis was carried out [30-33]. PM1, PM3 and PM5
plates were utilized for the experiment (plate compositions
in Additional file 4). 284 different conditions were tested,
of which 95 were carbon sources, 95 nitrogen sources
and 94 were other nutrient supplements. As a validation
exercise, batch culturing of Msm in the reference medium
was carried out and the growth profile compared with thatFigure 4 Phenotypic microarray analysis. (a) Correlation plot for nutrien
replicates was found to be 0.93. In scatterplot, Pearson correlation coefficie
plate (PM1) where x and y-axis represents time in hours and Omnilog units
ation rate. (c) Level plot (PM1) indicating dye reduction which is coloured
represents nutrients present in the 96-well plate.obtained from the well containing glucose in the PM1
plate. A consistent pattern in growth profiles was observed
in the batch culture as well as the PM well, containing
D-glucose as the carbon source (Additional file 5).
We also observe high levels of consistency between
the two biological replicates in PM plates. Scatter plot
of kinetic data at 48 hours growth for all the nutrient
sources shows high correlation (R = 0.93) between the
biological duplicates (Figure 4a).
Figure 4b shows XY plots of the 95 conditions of PM1
plate illustrating growth curves under different carbon
sources. We observe that certain carbon sources are more
preferable for growth as compared to the others. Figure 4c
showing level plot of PM1 plate capturing the extent of dye
reduction and in turn the extent of respiration (XY and
Level plot for PM3 and PM5 in Additional file 6).
Correlation between the two replicates is evident from
these plots as well. In the level plot, it can be seen that
lyxose is a good carbon source, albeit poorer than glucose,
whereas phenyl ethylamine is not. Pyruvate on the othert plate (PM1, 3 and 5) of biological replicates at 48hrs. R value for the
nt and linear regression line are shown (b) XY plot of carbon source
respectively. The Omnilog unit is a standard representation of respir-
based on the Omnilog units. X-axis represents time in hours and y-axis
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Few example of growth supporting compounds are
summarized in Table 1. Similar insights are obtained
for all the carbon and nitrogen sources studied here,
summarized in Additional file 4.
Of all nutrient conditions studied, 167 nutrients
support growth, 96 carbon and nitrogen sources show
moderate growth, while 21 sources do not support
any significant growth (Additional file 4). Some notable
observations are: (i) Tween is considered to be a source ofTable 1 List of substrates used as carbon source, respective m
catalyzing the substrates
Source Source type and metabolic pathways
L-Proline Aminoacid, TCA, oxologlutarate, Glu
D-Xylose Carbohydrate, Pentose and glucuronate
interconversions
D- Mannitol Carbohydrate, Glycolysis, fructose, mannose
L-Rhamnose Carbohydrate, Glycolysis, fructose, mannose
D- Fructose Carbohydrate, Glycolysis, fructose
Alpha- D Glucose Carbohydrate, Glycolysis
L-Arabinose Carbohydrate, Glycolysis, G3P, Pentose
and glucuronate interconversions
D-Saccharic acid Carbohydrate, Glycolysis Ascorbate and
aldarate
Succinic acid Carboxylate, TCA
D-Mannose Carbohydrate, Glycolysis, fructose, mannose
D-Sorbitol Carbohydrate, Glycolysis, mannose
Glycerol Carbohydrate, Glycolysis, glycerate
D-Gluconic Acid Carbohydrate, Glycolysis
L-Lactic acid Carboxylate
D-Galactonic acid
- gamma -Lactone
Carboxylate, Glycolysis, Glactose metabolism
D,L-Malic acid Carboxylate, TCA, malinate
D-Ribose Carbohydrate, Pentose and glucuronate
interconversions
1,2-Propanediol Alcohol, Glycolysis, pyruvate metabolism
Alpha-Keto-Butyric Acid Carboxylate, Glycine, serine and threonine
metabolism
Myo-Insitol Carboxylate, Galactose Metabolism
Fumaric acid Carboxylate, TCA
L-Alanine Aminoacid, TCA, oxaloacetate, Pyruvate
Pyruvic acid Carboxylate, Pyruvate metabolism
Msm is observed to have higher growth in presence of the carbon sources mention
as MSMEG_(number).fatty acids such as oleic acids. Tween 80 is known to
significantly promote aerobic growth by improving O2
transfer, while only a small amount is known to be
degraded and metabolized through the TCA cycle as part
of the central metabolism for biomass synthesis [34]. It is
utilized when given as a sole carbon source but not in
combination with glucose. When supplied as a carbon
source, Msm has a longer log phase in the growth curve,
while as a nitrogen source it is used very efficiently which
is not seen in other mycobacteria (Table 2). (ii) Serine isetabolic pathways and genes coding for enzymes
Gene locus Enzyme catalyzing substrate utilization
0943, 1413, 2681 pyrroline-5-carboxylate reductase,
ornithine-oxo-acid transaminase,
proline imino-peptidase
6021 xylose isomerase
5576 D-mannonate oxidoreductase
0589 L-rhamnose isomerase
3094 , 0085 oxidoreductase, zinc-binding
dehydrogenase, PTS system,
Fru family protein, IIABC components
2136, 1363 Phosphogluco mutase, glucokinase
1675 L-arabinose isomerase
6117, 0455 Glucarate dehydratase, aldehyde
dehydrogenase
5524 , 5525, 0417, 0418 succinyl-CoA synthetase subunit
alpha and beta
1834 Phosphomanno mutase/phosphogluco
mutase
3094, 3605 oxidoreductase, zinc-binding dehydrogenase,
sorbitol dehydrogenase
6229 glycerol kinase
1274, 0453 gluconolactonase, shikimate kinase
2512 lactate 2-monooxygenase
6177 Galactonate dehydratase
2551, 2910 Malate:quinoneoxido reductase,
Fumarate hydratase class
4585 ribokinase
0496, 0497, 1546, 1547 Propanediol dehydratase
3183, 3532 threonine dehydratase, serine/threonine
dehydratase family protein
2762, 3116, 3210 inositol-1-monophosphatase
2985, 5240, 0417 Fumarate hydratase class I, anaerobic,
fumarate reductase iron-sulfur subunit
0688 aminotransferase
2471,4323, 4711, 4712 pyruvate dehydrogenase
ed in the table. The gene locus mentioned should be read
Table 2 Comparison between M. tuberculosis and M.
smegmatis for nutrient utilization
Carbon source Mtb Msm Carbon source Mtb Msm
2-oxoglutarate ✓ NA Oxalomalate ✓ NA
Acetate ✓ ✓ Propanoate X ✓
Acetoacetic acid ✓ NA Pyruvate ✓ ✓
Adenosine X X D-serine ✓ X
D-alanine ✓ ✓ D-tagatose X NA
L-alanine ✓ ✓ D-trehalose ✓ ✓
L-asparagine ✓ ✓ Tween 20 ✓ ✓
Butyrate ✓ ✓ Tween 40 ✓ ✓
Caproic acid ✓ ✓ Tween 80 ✓ ✓
Citrate ✓ ✓
D-fructose-6-phosphate ✓ ✓ Nitrogen source
D-glucose-6-phosphate ✓ ✓ L-Alanine ✓ ✓
D-glucose ✓ ✓ Allantoin X ✓
L-glutamate ✓ ✓ L-Asparagine ✓ ✓
L-glutamine ✓ ✓ L-Aspartic acid X ✓
Glycerol ✓ ✓ L-Cysteine ✓ ✓
Glycine ✓ NA D-Galactosamine ✓ ✓
L-lactate ✓ ✓ D-Glucosamine X ✓
D-malate X ✓ L-Glutamic acid ✓ ✓
L-malate ✓ ✓ L-Glutamine ✓ ✓
D-mannose X ✓ L-Ornithine ✓ ✓
Methyl-pyruvate ✓ ✓ D-Serine ✓ ✓
Mono methyl-succinate ✓ ✓ L-Serine ✓ ✓
N-acetyl-glucosamine X ✓ L-Threonine X ✓
The nutrient sources in bold indicate the differential utilization by Msm and
Mtb. (✓=growth, X=no growth, NA=not available).
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L-serine ammonia lyase. The enzyme is expected to
be expressed only in the absence of glucose and the
pathway becomes active in anaerobic conditions, similar to
that observed in E. coli [35]. L-Serine can be used as a
carbon source by Msm but not by other mycobacterial
species [31]. (iii) Alanine is also deaminated to produce
pyruvate, which is then converted to CO2 and acetyl-CoA.
The reaction is known to be catalysed by alanine
dehydrogenase, which is also present in Mtb [36,37]. (iv)
Acetic acid mediated growth is also observed in Msm,
indicating the presence of active gluconeogenesis pathways.
(v) Acetamide did not favour growth and is consistent with
earlier reports that it supports growth only in specially
constructed inducible strains with conditional expression
[38]. (vi) Formate is typically utilized by bacteria as a
carbon source in the tetrahydrofolate biosynthesis, but in
Msm it did not support growth, as the other required
essential compounds in the central metabolism cannot be
synthesized from this compound.From the XY and level plots, it can be seen that some
conditions yield a similar phenotype. In order to identify
which conditions show similar effect on the growth of
the organism, a clustering exercise was carried out, from
which distinct clusters were obtained depending upon the
extent of utilization of the carbon source. The clustergram
shown in Figure 5a indicates 3 major clusters as observed
for PM1, the first referring to those conditions that do not
support any significant growth, whereas clusters 2 and
3 refer to those showing high and moderate growth
respectively. Carbon sources glucose, fructose, xylose,
alanine, succinic acid and sorbitol all group into the
high growth cluster while TCA intermediates, sucrose,
maltose and Tween 20, Tween 40 and Tween 80 are
found in the moderate growth category. Similarly for
PM3 and PM5 plates, we find 2 major high growth and 4
moderate to lower growth clusters (clusters obtained for
PM3 and PM5 are given in Additional file 7) referring to
high growth and moderate growth categories. We also
compare them across plates, by clustering them all together
and find that the explored set of nutrient sources all map
into six growth-pattern types (Figure 5b). Overall, nutrients
enhancing growth of the organism were seen to be
clustered together while those that do not support growth
clustered separately. The nutrients such as hydroxylamine,
2-deoxy-adenosine, guanine and formic acid form a cluster
together, all of them not capable of supporting growth in
Msm. An enlarged portion of the figure is shown for the
high growth cluster (Figure 5c), which describes the
extent of variation in cellular respiration and thus
growth under different conditions. For example, thymidine,
phenylethylamine, inosine, mucic acid and alpha-methyl-D-
glucoside group into one low growth cluster while
D-galactose, L-aspartic acid, lactulose and L-fucose
group into moderate growth cluster. It is interesting
to observe that carbon sources D-xylose, L-lyxose and
D-ribose group along with nitrogen sources uric acid and
L-cysteine indicating that they have a similar influence on
metabolism in the cell. These compounds enter metabolism
at different points in the network and yet yield similar
phenotypes perhaps due to a similar emergent effect.
Rationalizing phenotypic behaviour by integrating
transcriptome data with pathways
Mapping gene expression values onto different enzymes
in the metabolic network illustrate the various metabolic
flows that are occurring in Msm in the reference condition,
as shown in Figure 6. Pathways of the central carbon
metabolism, TCA cycle, glyoxylate shunt, glycolysis and
fatty acid biosynthesis, all appear to be feasible paths
amongst the 73 super-pathways [27]. Among 284 conditions
tested in PM, around 135 points mapped onto the KEGG
metabolic network. Additional file 8 illustrates these points
in a biochemical network diagram. Using this as a reference
Figure 5 Clustering analysis of PM plates. (a) Clustering of different carbon sources. The colour bar indicates low to high utilization of different
carbon sources. (b) Clustering of the nutrient mediated growth across all the plates, each column represents a well and each row represents time
point (0-96 hrs, top to bottom), color bar ranges from blue to red depicting low to high respiration rate. (c) Cluster for high growth promoting
nutrients. The well numbering and corresponding metabolite details for the three PM plates are given in the supplementary (Additional file 3).
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phenotypic behaviour of Msm. The mapped compounds
reflect that a vast portion of the network is indeed probed.
Transporters for uptake of nutrients
For a compound to serve as a nutrient source, it needs
to be taken up by the cell. Such uptake takes place with
the help of specific transporters. We identify transporters
from the genome sequence and then feasibility of
their activity through gene expression data. About 282
transporters were annotated by our analysis and amongstthem we found about 60 to be expressed in the refer-
ence condition (glucose as carbon source) (shown in
Additional file 9). It is known that a gene cluster com-
prising MSMEG_2116 to MSMEG_2120 forms a part
of the glucose-sucrose subfamily in phosphotransferase
system (PTS) [11]. The expression of this cluster seems to
be lower but these are known to be constitutive as com-
pared to other transporters. This PTS also comprises of
trehalose, GlcNAc (N-acetylglucosamine), and dihydroxy-
acetone (MSMEG_2121 to MSMEG_2124) permeases
which are expressed. The transporters for fructose such as
Figure 6 Metabolic pathway map for Msm. The KEGG metabolic map overlaid with gene expression data and nutrients utilized from PM
analysis. The nodes represent metabolic compounds and edges represent genes involved in the reactions (red lines: gene expression, black dots:
compounds identified from PM but not directly connected to enzymes expressed in reference condition).
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to be expressed in the reference condition itself. Msm has
glucose-6-phosphate isomerase (MSMEG_5541) for its
utilization. Fructose is also known to have another mech-
anism of utilization via the expression of fructose-specific
PTS composed of EI (ptsI), HPr (ptsH), and IIABCFru
(fruA) (MSMEG_0084 to MSMEG_0088). However the
expression here is lower except in the first locus. This
cluster is known to be inducible in the presence of fruc-
tose as the sole carbon source. Indeed, high growth is ob-
served in the PM plate, with fructose as the carbon
source. Additional file 10 lists the possible transporters as
deduced from the genome sequence and highlights those
among them that are expressed under reference nutrition
conditions. Transporters for glucose, xylose are seen to be
expressed, providing first level explanation for utilization
of these compounds as carbon or nitrogen sources. It has
been reported that Msm can utilize different sugars indi-
cating activation of various transporters and hence also
changes in gene expression levels [11,39-41].
Connecting nutrient sources to metabolic pathways
Next, we study, if a given source compound can be
mapped onto specific pathways in Msm, through which
it can enter metabolism [18]. About 135 of thesecompounds are direct metabolites in the network and
hence growth patterns with them are easily interpreted.
Several more compounds can be linked with a metabol-
ite in the network with one or few steps. In such cases,
we study if the enzymes corresponding to their conver-
sion can be detected in the genome. Additional file 4
lists these cases. One example is D-Mannitol, which is
known to get converted into D-fructose then to fructose
6-phosphate, thus entering glycolysis [42]. A transporter
for this can be traced from the genome sequence
(MSMEG_5574). It is not expressed highly in the refer-
ence condition, but perhaps gets induced when mannitol
is the sole carbon source. Similar behaviour is observed
for trehalose, sorbitol and D-saccharic acid sources [11].
There are many lines of evidence from individual mo-
lecular biology studies to support the functional roles of
these molecules [43-48]. Put together, they explain why
these compounds serve as carbon or nitrogen sources
that promote bacterial growth.
Another example is the conversion of serine into many
central carbon metabolites through the glycolysis pathway
and then to glycine and cysteine thus supporting growth
[34]. The central carbon metabolism in Msm is repre-
sented in Additional file 3. Utilization of the range of
carbon sources shows the repertoire of possibilities for
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mannose, D-glucose and many other polyols, pentoses,
hexose and also complex sugars enhance growth as sup-
ported by literature [39-41]. The alternate carbon sources
such as L-proline, rhamnose, xylose and others are also
being utilized for growth in Msm indicating these can in-
duce their uptake and successful utilization. Glycerol can
be taken up by a facilitator (MSMEG_6758) and used by
the enzyme glycerol kinase (MSMEG_6759 shown to be
expressed abundantly) to form glycerol 3-phosphate which
can then enter central carbon metabolism. The observa-
tion about absorption and utilization of maltose is also in
line with other experimental evidences, showing very low
or retarded growth. Galactose and lactose show only mod-
erate growth, consistent with the observation that the cor-
responding enzymes and transporters show poor
expression values [11,39-41].
It is not clear whether there are any transporters for
utilisation of trehalose from the external medium in
Msm. Nevertheless, it seems to be enabling growth in
the bacterium. It is possible that it can be involved in
central carbon metabolism as well as be a component of
the cell wall in the form of conjugates of mycolate, such
as trehalose dimycolates and trehalose monomycolates
[44,46]. Many of the TCA intermediates such as succinic
acid, citric acid seem to promote growth. This is again
consistent with the observation, that many of the central
carbon metabolism genes are constitutively expressed in
Msm. We also observe acetate and oleic acid (derived
from Tween 80) being utilized for growth. This observa-
tion is consistent with known biochemical studies that
glyoxylate shunt is prominent for anaplerosis in the bac-
terium allowing the utilization of acetate or fatty acids as
the sole carbon sources while it allows the regeneration
of the four-carbon malate from glyoxylate and acetyl-
CoA for biosynthetic processes. The shunt can also re-
plenish amino acids such as glycine and serine [34].
Amino acids such as L-Proline, L-Alanine and dipep-
tides such as L-Alanyl-Glycine seem to promote growth
as nitrogen sources [37,49-51]. All other amino acids
tested are also able to support growth either highly or
moderately, indicating the ability of Msm to adapt to a
wide variety of nitrogen sources and supplements. The
genes involved in purine salvage pathways seem to be
moderately expressed in Msm. Adenosine as a sole car-
bon source does not support growth, consistent with
earlier suggestions in literature as well [31]. Examin-
ation of the gene expression values of enzymes involved
in a pathway that salvages adenosine, indicates that the
pathway is infeasible since enzymes adenosine deaminase,
adenosine kinase and adenine phosphoribosyltransferase
are virtually non-expressed under the conditions studied.
However, when adenosine is supplied as a nitrogen source
along with glucose as the carbon source, small extent ofutilization is observed. An enzyme unique to mycobacteria,
5-methylthioadenosine phosphorylase (MSMEG_0990),
that converts adenosine to adenine and alpha-D-ribose-
phosphate is moderately expressed, perhaps presenting the
only feasible way for adenosine utilization [52]. Thus
the low activity of purine salvage pathways makes de novo
biosynthesis of purine nucleotides highly essential for the
survival of the organism, presenting targets for antimyco-
bacterial drugs [53-56]. In fact, analog-based inhibitions of
the de novo biosynthesis pathway enzymes are already
under consideration as anti-tubercular drugs. Guanosine
can be efficiently used by Msm as the same enzyme
(MSMEG_0990) can cleave inosine and guanosine as well
[52]. Overall, the differences in growth patterns under dif-
ferent conditions are explained by (a) presence or absence
of a transporter for nutrient uptake, (b) presence and the
expression level of the utilizing enzymes.
Microarray data of Mtb shows about one-fourth of the
genes are consistently expressed under standard nutri-
tion conditions in in vitro cultures [57]. Phenotypic
microarray studies have been reported for Mtb, using a
similar Biolog experimental setup [31,32]. Comparison
of the growth patterns in Msm and Mtb, as observed
from phenotypic microarray experiments, reveals that
the two species show similar growth behaviour in most
cases. This implies similar metabolic flow for most of
the studied probes (Table 2). Exceptions to this are com-
pounds D-malate, D-mannose, N-acetyl glucosamine,
propoanoate, allantoin, L-aspartic acid and L-threonine
which serve as nutrients to Msm but not to Mtb, while
D-serine is the only compound that serves as a nutrient
to Mtb but not to Msm (Table 2). Thus, overall, Msm
can utilise most of the carbon sources and nutritional
supplements as compared to Mtb and other mycobacter-
ial species. Tween can be used as a sole carbon source
in both but unlike in Mtb, it cannot be utilised in com-
bination with glucose in Msm. Thus, it can be seen that
31 nutrient sources are common and 9 are unique be-
tween Msm and Mtb.
Discussion
Phenotype of an organism is the cumulative effect of the
genetic makeup and interaction of many composite mole-
cules in the organism. Biochemical alterations in metabol-
ism would be necessary to support [34,58] phenotypic
variations of that organism. Given the high levels of inter-
connectedness in organisms, as evidenced by high com-
plexity in genome-scale networks, there are many ways by
which metabolic alterations can influence a system. Thus,
it is important to evaluate the organism in a multitude of
sets of scenarios that might occur in its environment.
Phenotypic microarray studies offer such a platform where
such evaluation of various different arrays of nutrient sup-
plement and chemical environments can be carried out in
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the added advantage of providing a direct readout of cellu-
lar respiration, enabling us to visualise and analyse growth
patterns of the particular organism [13,14,19,31,33,59,60].
Most of the mycobacterial species exhibit common
physiological traits such as adaptation to hypoxic condi-
tions by maintaining itself in a dormant state. It is well
known that Mtb survives inside the host by altering its
metabolic requirements [61,62]. Msm has comparable
physiological responses during dormancy as Mtb, thus
making it a feasible model to study metabolic alterations
and gain mechanistic insights [34,63].
Knowledge inferred from transcriptomic analysis, aids
in unraveling the attainable metabolic routes in the or-
ganism. Adaptation to different environmental scenarios
is due to induced variation in gene expression profile.
However, it is a challenging task to predict phenotypic
behaviour of the organism from its genotype. In order to
rationalize the genome-phenome relationship, it has be-
come essential to integrate information obtained from
such high-throughput techniques. Integrating knowledge
of phenotypic response in different conditions with the
transcriptome data, as observed in this study, leads to a
bird’s eye-view of genome-transcriptome–phenome per-
taining to metabolism in mycobacteria. Such informa-
tion can be used as direct inputs to build systems level
models to comprehend large number of parameters
simultaneously. The ultimate use of this systems level
study is in understanding metabolic adaptations in dif-
ferent conditions such as in vivo environments for
pathogens.
Conclusion
In this study we gain comprehensive understanding
of metabolic repertoire of Msm and its phenotypic response
to different nutrient conditions. It can be inferred that
many alternate nutrients are capable of being efficiently uti-
lized by Msm as carbon and nitrogen sources when com-
pared to Mtb and M. bovis strain. The comparative study
for carbohydrate import systems of Mtb and Msm reveals
larger number of genes involved in the mechanism and also
expressed in reference condition [11]. This suggests the
possibility of Msm to use alternate carbohydrates when
present in the environment and also its relative faster
growth when compared to the pathogenic counterparts.
While the genes responsible for central metabolism are
expressed in the reference medium, the expression of add-
itional genes cannot be ruled out when provided with alter-
nate nutrients. Thus, in the present study, experiments
were performed to analyse the expression profile of the or-
ganism to infer the feasible metabolic pathways and also to
derive the set of nutrients favourable for its growth. Integra-
tion of transcriptomic and phenotypic data along with func-
tional annotation of the genome provides us insights intothe biochemical repertoire of pathways possible when the
medium is supplemented with an array of nutrients.
Methods
Functional annotation of Msm genome
Genome sequence for Msm was downloaded from TB
Database (TBDB) [10]. The genome annotation as avail-
able for each locus was obtained from multiple sources,
mainly TB Database [10], Smegmalist, Tuberculist [24]
and xBASE [64]. Bidirectional BLAST searches [65] were
performed to identify the homologous proteins present
in Mtb. Functional categories were assigned to these ho-
mologues based upon Tuberculist classification where
possible. In certain cases, more than 1 functional cat-
egory was identified for some genes in Msm using the
above method, so the most relevant functional category
was assigned by manual curation. Pathway assignments
for enzymes were initially obtained from an automated
protocol from BioCyc [27]. The individual gene annota-
tions were systematically compared to those from TBDB
and verified for consistency. Additional pathway assign-
ments were added as necessary.
Transcriptome analysis
a) Strain and culture condition
M. smegmatis MC2 155 wildtype culture was grown in
Middlebrook 7H9 media until it reached 0.2-0.3 O.D600.
Once the O.D was reached, 20 ml of the culture was pel-
leted down, and the supernatant was discarded. The pel-
let was resuspended in 100 μl of 1× PBS. The pellet was
snap freezed in liquid nitrogen and stored in -80C until
RNA extraction was carried out.
b) RNA extraction
RNA extraction was done using Qiagen’s RNeasy minikit
(Cat#74104). The RNA quality was checked using Bioanaly-
zer. Labelling was done using Agilent’s Quick-Amp labeling
Kit. Random hexamer method of labeling was done
followed by T7 promoter based-linear amplification to gen-
erate labeled complementary RNA (One-Color Microarray-
Based Gene Expression Analysis). Hybridization was
performed using Agilent’s In situ Hybridzation kit 5188–
5242. Chips used for microarray were customized for M.
smegmatisMC2 1558×15k Array AMADID: 020791 (Geno-
typic Technology, Bangalore, India).
c) Transcriptome data analysis
The raw data obtained from experiments have been nor-
malized using GeneSpring GX 12.6.1 software. Intra-array
normalization deals with variability within a single array. In
intra-array normalization, gProcessed signal (dye normal-
ized background subtracted signal intensity) is log trans-
formed and then for each of the array elements, the 75th
percentile value is calculated separately. In each sample the
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tracted by the calculated 75th percentile value of the re-
spective array and expression values are obtained. Similarly
50th and 25th percentile normalization was calculated for
the dataset.
d) Clustering
Hierarchical clustering of the normalized data was per-
formed using GeneSpring GX 12.6.1 software. Pearson
correlation coefficient to measure similarity between ex-
pression profiles and average linkage method was used
for clustering genes.
Metabolic network feasibility analysis
Analysis was carried out to map the gene expression
data onto the metabolic network derived from KEGG
[26] and Biocyc [27] for M. smegmatis MC2 155. Based
upon the expression profile for each locus in the individ-
ual pathway, we mapped the corresponding 25th, 50th
and 75th percentile values to infer feasible metabolic
pathways in the network.
Phenome analysis
a) Bacterial strains, growth conditions and chemicals
Mycobacterium smegmatis MC2 155 were cultivated at
37°C in Middlebrook 7H9 broth with 0.2% (vol/vol) gly-
cerol and 0.1% (wt/vol) Tween 80 or on Middlebrook
media 7H10 agar plates supplemented with 0.2% (vol/
vol) glycerol and supplemented with OAD (oleic acid, al-
bumin, dextrose).
b) PM measurements
Phenotype microarray experiments were carried out
following standard Biolog Inc. (http://www.biolog.com/)
protocols as provided by the supplier. To prepare the in-
oculum for Phenotypic microarray plates (PM01 for car-
bon source, PM03 for nitrogen source, PM05 for other
nutrient supplement), bacteria colonies were grown in
Middlebrook 7H10 medium containing 10% (v/v) albumin
dextrose (AD) enrichment and 0.05% (v/v) Tween 80. Bac-
teria were harvested at 48 hrs. The M. smegmatis strains
were re-suspended in inoculating fluid so as to have 81%
transmittance. The Biolog plates PM03 and PM05 contain
dextrose as a carbon source in the PM additive.
PM plates were inoculated with 100 μl of the mixture
made up with the following volumes per plate: Middlebrook
7H9 broth at 1.2× (10 ml), Dye mix G at 100× (0.12 ml),
PM additive appropriate to the plate at 12× (1 ml) and bac-
teria in the media at 13.64× (0.88 ml). For each plate, the
final volume of mixture was 12 ml. After plate inoculation,
the plates were transferred to an OmniLog (Biolog, Inc.)
incubator and incubated at 37°C for 4 days and monitored
for color change due to dye reduction in the wells. To havebiological replicates, separate inocula were used in the
experiment.
c) Data processing and analysis
Data were analysed initially with OmniLog-PM software
for gathering the kinetic values or respiration rates.
Then for further analysis, data aggregation, discretization
and clustering of the biological replicates in each PM
plate types were carried out using OPM package avail-
able in R. MATLAB R2011b Toolboxes were used for
clustering and correlation analysis across PM plates.
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